As filed with the Securities and Exchange Commission on February 19, 2026 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 20-F _____________________________________ (Mark one) o REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXC ...

Core Insights - Royal Philips published its Annual Report 2025, which will be discussed at the Annual General Meeting of Shareholders on May 8, 2026 [1] - The report has been filed with the Netherlands Authority for the Financial Markets in European Single Electronic Format and is expected to be filed with the U.S. Securities and Exchange Commission [2] - The Annual Report 2025 is accessible to shareholders and interested parties online, with printed copies available upon request [3] Company Overview - Royal Philips is a leading health technology company focused on improving health and well-being through innovation [4] - The company specializes in diagnostic imaging, ultrasound, image-guided therapy, monitoring, and personal health solutions, employing approximately 64,800 people and generating sales of EUR 18 billion in 2025 [5]

2026年2月10日， 飞利浦公司（Philips） 发布了其2025年第四季度和全年财务报告。 财报指出，2025年第四季度飞利浦销售额为 50.97亿欧元 ，同比增长1%，调整后EBITA为 7.7亿欧元 。全年销售额为 178.34亿欧元 （约合 1462亿人民币 ） ，同比 下降1%，调整后EBITA为 21.95亿欧元 ，EBITA率提升至12.3%。 | | Q4 2025 | Q4 2024 | | --- | --- | --- | | Sales | 1,422 | 1,426 | | Nominal sales growth | 0% | 5% | | Comparable sales growth 1 | 7% | 7% | | Income from operations | 92 | 58 | | as a % of sales | 6.5% | 4.1% | | EBITA 1 | 119 | 88 | | as a % of sales | 8.3% | 6.2% | | Adjusted EBITA 1 | 235 | 214 | | as a % of sales | 16. ...

February 12, 2026 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the availability of the InkSpace Imaging Snuggle™ pediatric body array coil for Philips 3.0T MRI systems. Designed specifically for pediatric patients, the Snuggle coil has been optimized and validated for use with Philips 3.0T MRI systems, bringing enhanced comfort for children and efficient, high-quality imaging for clinicians. Young patients often find MRI exams chall ...

Core Insights - Koninklijke Philips (PHG) reported a fourth-quarter 2025 earnings of €0.41 per share, recovering from a loss of €0.35 per share in the same quarter last year [1] - The company's sales increased by 1.1% year-over-year to €5.09 billion, with comparable sales rising by 7% across all segments [1][2] - The company anticipates 3%-4.5% comparable sales growth and an adjusted EBITA margin between 12.5% and 13% for 2026 [10] Sales Performance - Comparable order intake increased by 7% year-over-year in the fourth quarter, with growth geographies showing a 15% increase, primarily driven by Personal Health [2] - Sales in Mature geographies grew by 4%, mainly due to strong contributions from North America and Connected Care [2] - Personal Health revenues grew by 9% year-over-year to €1.11 billion, with comparable sales increasing by 14% [4] Segment Analysis - Diagnosis & Treatment revenues declined by 2% year-over-year to €2.40 billion, although comparable sales increased by 4% [3] - Connected Care revenues remained stable at €1.42 billion year-over-year, with comparable sales up by 7% [3] - Other segment sales amounted to €155 million, reflecting a 2.6% year-over-year increase [4] Financial Metrics - Gross margin contracted by 600 basis points to 44.9% year-over-year [5] - Adjusted EBITA increased by 13.4% year-over-year to €770 million, with an EBITA margin expanding by 160 basis points to 15.1% [6] - Free cash flow was reported at €1.2 billion, compared to €1.28 billion in the year-ago quarter [9] Balance Sheet Overview - As of December 31, 2025, cash and cash equivalents were €2.40 billion, up from €1.91 billion as of September 30, 2025 [9] - Total debt decreased to €8.084 billion from €8.385 billion as of September 30, 2025 [9] - Operating cash flow was €1.39 billion, slightly down from €1.45 billion in the previous year [9]

We recently published 10 Stocks Delivering Massive Returns. Koninklijke Philips NV (NYSE:PHG) was one of the best performers on Tuesday. Philips soared to a new 52-week high on Tuesday, as investors cheered its strong earnings performance and upbeat business outlook over the next two years. At intra-day trading, the stock soared to its highest price of $33.44 before trimming gains to finish the session just up by 11.11 percent at $32.91 apiece. During its earnings call, Koninklijke Philips NV (NYSE:PHG ...

Core Insights - Royal Philips, a leader in health technology, has announced the SEISMIC research consortium, which aims to transform neurosurgery through the integration of minimally invasive surgical techniques and advanced imaging technologies, supported by EUR 23.5 million in public funding and EUR 14.9 million in contributions from industry partners [1][6]. Group 1: Project Overview - The SEISMIC project will focus on improving patient care by shifting from open brain surgery to minimally invasive procedures, utilizing advanced imaging and precision navigation [2][4]. - The project will develop an integrated suite of technologies, including real-time surgical navigation combining ultrasound and live X-ray imaging, and minimally invasive biopsy and treatment techniques [5][6]. - The total budget for the five-year research program is EUR 38.4 million, which includes eight clinical studies to validate technical solutions for minimally invasive neurosurgery [6][7]. Group 2: Medical and Societal Impact - Neurological conditions, such as hemorrhagic stroke and brain tumors, are significant contributors to global health issues and socioeconomic costs, necessitating urgent minimally invasive treatment options [3][4]. - The SEISMIC project aims to reduce procedure times, minimize surgical trauma, and accelerate patient recovery, thereby improving clinical outcomes and expanding access to specialized neurosurgical care [7]. Group 3: Specific Conditions Addressed - The project will specifically target three critical neurological conditions: intracerebral hemorrhage, subdural hematoma, and brain tumors, focusing on enhancing surgical techniques and diagnostic methods [5][13]. - For intracerebral hemorrhage, the project will explore the use of real-time imaging to guide minimally invasive drainage devices [5][13]. - In addressing subdural hematoma, the team will investigate a combined procedure for drainage and embolization to prevent recurrence of bleeding [13]. - For brain tumors, SEISMIC will assess the use of cryoablation and focused ultrasound-enhanced liquid biopsy to reduce the need for open surgery [13].

Core Insights - The SEISMIC project, coordinated by Philips and funded by the EU's Innovative Health Initiative, aims to revolutionize neurosurgery by integrating advanced imaging and minimally invasive techniques to treat brain bleeding and tumors [2][3] Group 1: Project Overview - The SEISMIC project has a total budget of EUR 38.4 million, which includes EUR 23.5 million in public funding and EUR 14.9 million in in-kind contributions from industry partners [2] - The project will span five years and include eight clinical studies to validate technical solutions for minimally invasive neurosurgery [2] Group 2: Objectives and Innovations - The project seeks to shift from open brain surgery to minimally invasive procedures, enhancing patient care through advanced imaging and precision navigation [3][5] - SEISMIC will develop technologies such as real-time surgical navigation combining ultrasound and live X-ray imaging, simulation platforms for clinician training, and minimally invasive biopsy and treatment techniques [8] Group 3: Focus Areas - The project will address three critical neurological conditions: intracerebral hemorrhage, subdural hematoma, and brain tumors, which require surgical intervention for patient survival and quality of life [8][14] - Specific innovations include using real-time imaging for minimally invasive drainage of intracerebral hemorrhage, a combined procedure for subdural hematoma, and cryoablation for brain tumor treatment [14]

Group 1 - Gold stocks continue to rise, with significant increases in companies such as WanGuo Gold Group (up 9.39%), Zijin Mining (up 3.5%), and Lingbao Gold (up 7.24%), driven by fluctuating gold prices and rising interest rate cut expectations [1][2] - Zijin Mining has approved a three-year production plan for major mineral products from 2026 to 2028, outlining clear production targets [1] - China Duty Free Group reported a 14.71% year-on-year increase in duty-free shopping amounts, totaling 11.585 billion yuan since the policy adjustment [1] Group 2 - Mongol Mining shares rose over 15% during trading, reflecting its transition from a single coking coal producer to a multi-mineral producer, including gold and copper [2] - Semiconductor manufacturer SMIC reported a 12.8% year-on-year increase in Q4 2025 revenue, reaching $2.489 billion, with a 60.7% increase in attributable profit [2] - Health 160 experienced a significant drop of nearly 40%, with its market value falling below 20 billion HKD, indicating a major reversal in its stock performance [2] Group 3 - Xiaomi Group shares increased nearly 5% following a live broadcast by its founder, emphasizing ongoing investments in technology and product development [3] - Zhizhu shares rose over 10% this week, with a cumulative increase exceeding 70%, driven by the launch of a new anonymous model by OpenRouter [3] - Jiantao Group stocks rose due to increased demand for high-end copper-clad laminates driven by AI computing power [3] Group 4 - Jaguar Uranium's stock opened over 35% higher on its debut in the US market but later fell by 23.25%, indicating volatility in its initial trading [4] - NIO shares rose 1.43% as the CEO highlighted significant achievements and future plans for profitability by 2026 [4] - Sohu reported a 6% year-on-year revenue increase in Q4 2025, with a notable reduction in losses compared to the previous year [4] Group 5 - Ferrari's Q4 2025 revenue reached €1.8 billion (approximately $2.14 billion), exceeding expectations, with a positive outlook for 2026 [5] - Philips reported a 1% year-on-year sales increase in Q4, with adjusted EBITA surpassing market expectations, particularly in its personal health segment [5]

Core Insights - Philips CEO Roy Jakobs discusses the anticipated tariff impact in 2026 and the company's strategies to enhance margins despite existing pressures [1] Group 1: Tariff Impact - The company expects significant tariff implications in 2026, which could affect its operational costs and pricing strategies [1] Group 2: Margin Growth Strategies - Philips is implementing various strategies aimed at improving profit margins in the face of external pressures, indicating a proactive approach to financial management [1]